Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Chemomab Therapeutics Ltd ADR (NASDAQ: CMMB) closed at $1.65 up 0.61% from its previous closing price of $1.64. In other words, the price has increased by $0.61 from its previous closing price. On the day, 0.11 million shares were traded. CMMB stock price reached its highest trading level at $1.73 during the session, while it also had its lowest trading level at $1.605.
Ratios:
For a deeper understanding of Chemomab Therapeutics Ltd ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.49 and its Current Ratio is at 10.49. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
. In the most recent recommendation for this company, Maxim Group on May 13, 2024, initiated with a Buy rating and assigned the stock a target price of $4.
On May 06, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMMB now has a Market Capitalization of 10155943 and an Enterprise Value of 802419456.
Stock Price History:
The Beta on a monthly basis for CMMB is 0.48, which has changed by -0.80751175 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, CMMB has reached a high of $9.84, while it has fallen to a 52-week low of $1.60. The 50-Day Moving Average of the stock is -34.02%, while the 200-Day Moving Average is calculated to be -56.66%.
Shares Statistics:
For the past three months, CMMB has traded an average of 148.14K shares per day and 107990 over the past ten days. A total of 6.16M shares are outstanding, with a floating share count of 5.54M. Insiders hold about 9.98% of the company’s shares, while institutions hold 6.34% stake in the company. Shares short for CMMB as of 1765756800 were 8994 with a Short Ratio of 0.06, compared to 1763078400 on 16903. Therefore, it implies a Short% of Shares Outstanding of 8994 and a Short% of Float of 0.15.
Earnings Estimates
A detailed examination of Chemomab Therapeutics Ltd ADR (CMMB) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04. Analysts are recommending an EPS of between -$0.08 and -$0.08 for the fiscal current year, implying an average EPS of -$0.08. EPS for the following year is -$0.2, with 1.0 analysts recommending between -$0.2 and -$0.2.
